Heilongjiang ZBD Pharmaceutical Co., Ltd. (SHA:603567)

Market Cap	10.07B
Revenue (ttm)	3.12B
Net Income (ttm)	653.39M
Shares Out	939.40M
EPS (ttm)	0.69
PE Ratio	15.45
Forward PE	n/a
Dividend	0.20 (1.87%)
Ex-Dividend Date	n/a

Volume	6,532,700
Average Volume	4,881,300
Open	10.33
Previous Close	10.55
Day's Range	10.26 - 10.73
52-Week Range	9.81 - 13.63
Beta	0.25
RSI	48.61
Earnings Date	Apr 26, 2025

About SHA:603567

Heilongjiang ZBD Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of Chinese medicines in China. It offers cardiovascular and cerebrovascular, respiratory system, orthopedics, tumors, digestive system, anti-infection, mental nerve, genitourinary, and other disease fields. The company was founded in 1996 and is based in Hulin, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1996
• Employees: 2,545
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603567

Financial Performance

In 2023, SHA:603567's revenue was 3.14 billion, a decrease of -25.53% compared to the previous year's 4.21 billion. Earnings were 472.74 million, an increase of 154.93%.